https://stock.noler.com/us/stock/kuvatris-therapeutics-inc https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/accounts-payable https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/accounts-payable-related-parties-current https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/accounts-payable-related-parties-current-and-noncurrent https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/accounts-receivable https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/accrued-insurance-current https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/accrued-liabilities-current https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/accrued-professional-fees-current-and-noncurrent https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/accrued-salaries-current https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/additional-paid-in-capital https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/amortization-of-debt-discount-premium https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/basic-shares https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/cash https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/cash-and-equivalents https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/cash-and-restricted-cash-change-excluding-exchange-rate-effect https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/cash-flow-breakdown https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/class-of-warrant-or-right-number-of-securities-called-by-each-warrant-or-right https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/common-stock-value-outstanding https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/concept-stock-issued-tag-2 https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/convertible-debt https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/convertible-notes-payable-current https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/current-assets https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/current-liabilities https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/debt-face-amount https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/deferred-costs https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/deferred-income-current https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/deferred-income-noncurrent https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-accrued-liabilities https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/derivative-liabilities-current https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/diluted-shares https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/dilutive-securities https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/dilutive-shares https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/dividends-cash https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/effective-tax-rate https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/entity-listing-par-value-per-share https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/eps https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/eps-basic https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/fair-value-measurement-with-unobservable-inputs-reconciliations-recurring-basis-liability-value https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/financing-cash-flow https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/form-d-other https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/general-and-administrative-expense https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/income-tax https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/increase-decrease-in-accounts-payable-related-parties https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/increase-decrease-in-accounts-payable-trade https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/increase-decrease-in-deferred-charges https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/increase-decrease-in-other-current-assets https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/increase-decrease-in-other-operating-assets https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/increase-decrease-in-prepaid-expenses-other https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/incremental-common-shares-attributable-to-call-options-and-warrants https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/insider-transactions-warrants https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/interest-expense https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/interest-expense-nonoperating https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/issuance-of-stock-and-warrants-for-services-or-claims https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/legal-fees https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/level-3-liability-gain-loss-included-in-earnings https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/level-3-liability-issues https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/level-3-liability-settlements https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/litigation-reserve https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/long-term-notes-payable https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/net-income https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/net-income-loss-attributable-to-parent-diluted https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/notes-payable-current https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/operating-cash-flow https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/operating-expenses https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/operating-income https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/operating-loss-carryforwards https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/other-income https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/other-inventory-in-transit https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/other-noncash-expense https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/other-nonoperating-expense https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/other-prepaid-expense-current https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/paid-in-capital-shares-issued-issuance-costs https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/paid-in-kind-interest https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/preferred-shares-facts https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/preferred-stock-liquidation-preference-value https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/preferred-stock-value-outstanding https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/prepaid-insurance https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/pretax-income https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/pretax-income-domestic https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/proceeds-from-convertible-debt https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/proceeds-from-issuance-of-preferred-stock-and-preference-stock https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/profit-loss https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/public-float https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/repayments-of-convertible-debt https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/research-and-development https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/restricted-stock-value-shares-issued-net-of-tax-withholdings https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/retained-earnings https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/revenue https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/share-price https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/shareholders-equity https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/shares-authorized https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/shares-issued https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/shares-paid-for-tax-withholding-for-share-based-compensation https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/short-term-investments https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/stock-award-rsu-grants-in-period https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/stock-award-rsu-nonvested-number https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/stock-based-compensation https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/stock-compensation-unrecognized-cost-share-based-awards-other-than-options https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/stock-issued-value-of-shares-issued-for-stock-awards https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/tax-rate-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/tax-rate-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/tax-rate-reconciliation-nondeductible-expense-other https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/tax-rate-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/tax-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/tax-reconciliation-nondeductible-expense-other https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/tax-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/tax-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/tax-withholding-on-stock-awards https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/total-assets https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/total-liabilities https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/undistributed-earnings-loss-allocated-to-participating-securities-basic https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/kuvatris-therapeutics-inc/warrants-and-rights-outstanding